medical research

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study

Study Overview The study investigates the efficacy of three therapeutic agents—ripertamab, rituximab, and efgartigimod—in treating chronic inflammatory demyelinating polyneuropathy (CIDP),

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study Read Post »

Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals

Background and Rationale The rising prominence of neuroinflammatory processes in various neurological conditions has heightened the need for reliable biomarkers

Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals Read Post »

Post-pipeline headache after flow-diverting stenting for unruptured intracranial aneurysms: clinical, radiological findings, and proposed scoring system

Study Overview This study addresses the complications associated with flow-diverting stenting used to treat unruptured intracranial aneurysms. Specifically, it focuses

Post-pipeline headache after flow-diverting stenting for unruptured intracranial aneurysms: clinical, radiological findings, and proposed scoring system Read Post »

Scroll to Top